News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
719,121 Results
Type
Article (42645)
Company Profile (438)
Press Release (676037)
Multimedia
Podcasts (85)
Webinars (14)
Section
Business (208859)
Career Advice (2024)
Deals (36031)
Drug Delivery (107)
Drug Development (83750)
Employer Resources (173)
FDA (16490)
Job Trends (15126)
News (353126)
Policy (33171)
Tag
Academia (2650)
Accelerated approval (7)
Adcomms (27)
Allergies (92)
Alliances (51059)
ALS (107)
Alzheimer's disease (1464)
Antibody-drug conjugate (ADC) (165)
Approvals (16464)
Artificial intelligence (304)
Autoimmune disease (30)
Automation (18)
Bankruptcy (372)
Best Places to Work (11846)
BIOSECURE Act (19)
Biosimilars (111)
Biotechnology (331)
Bladder cancer (93)
Brain cancer (32)
Breast cancer (357)
Cancer (2746)
Cardiovascular disease (212)
Career advice (1692)
Career pathing (30)
CAR-T (184)
CDC (28)
Cell therapy (498)
Cervical cancer (20)
Clinical research (68378)
Collaboration (990)
Company closure (3)
Compensation (631)
Complete response letters (24)
COVID-19 (2751)
CRISPR (61)
C-suite (301)
Cystic fibrosis (113)
Data (2798)
Decentralized trials (2)
Denatured (29)
Depression (60)
Diabetes (302)
Diagnostics (6465)
Digital health (22)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (137)
Drug pricing (125)
Drug shortages (28)
Duchenne muscular dystrophy (119)
Earnings (88620)
Editorial (44)
Employer branding (21)
Employer resources (148)
Events (117113)
Executive appointments (839)
FDA (18014)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (890)
Gene editing (135)
Generative AI (22)
Gene therapy (379)
GLP-1 (783)
Government (4584)
Grass and pollen (4)
Guidances (179)
Healthcare (19179)
Huntington's disease (28)
IgA nephropathy (38)
Immunology and inflammation (151)
Immuno-oncology (5)
Indications (36)
Infectious disease (2911)
Inflammatory bowel disease (153)
Inflation Reduction Act (12)
Influenza (60)
Intellectual property (111)
Interviews (312)
IPO (16853)
IRA (45)
Job creations (3706)
Job search strategy (1435)
Kidney cancer (13)
Labor market (49)
Layoffs (516)
Leadership (18)
Legal (8004)
Liver cancer (78)
Lung cancer (389)
Lymphoma (193)
Machine learning (9)
Management (58)
Manufacturing (366)
MASH (86)
Medical device (13573)
Medtech (13578)
Mergers & acquisitions (19833)
Metabolic disorders (799)
Multiple sclerosis (95)
NASH (19)
Neurodegenerative disease (121)
Neuropsychiatric disorders (35)
Neuroscience (2129)
NextGen: Class of 2025 (6760)
Non-profit (4555)
Now hiring (46)
Obesity (419)
Opinion (231)
Ovarian cancer (95)
Pain (105)
Pancreatic cancer (105)
Parkinson's disease (179)
Partnered (22)
Patents (280)
Patient recruitment (137)
Peanut (49)
People (58953)
Pharmaceutical (86)
Pharmacy benefit managers (21)
Phase I (21508)
Phase II (30180)
Phase III (22297)
Pipeline (1567)
Policy (184)
Postmarket research (2602)
Preclinical (9232)
Press Release (67)
Prostate cancer (134)
Psychedelics (38)
Radiopharmaceuticals (270)
Rare diseases (458)
Real estate (6021)
Recruiting (66)
Regulatory (22947)
Reports (50)
Research institute (2421)
Resumes & cover letters (352)
Rett syndrome (9)
RNA editing (9)
RSV (49)
Schizophrenia (87)
Series A (155)
Series B (103)
Service/supplier (11)
Sickle cell disease (63)
Special edition (21)
Spinal muscular atrophy (152)
Sponsored (31)
Startups (3769)
State (2)
Stomach cancer (14)
Supply chain (73)
Tariffs (54)
The Weekly (54)
Vaccines (795)
Venture capitalists (49)
Weight loss (266)
Women's health (43)
Worklife (17)
Date
Last 7 days (492)
Last 30 days (2372)
Last 365 days (32606)
2025 (15274)
2024 (36321)
2023 (41024)
2022 (52296)
2021 (56803)
2020 (54955)
2019 (47417)
2018 (35698)
2017 (33027)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (739)
Alabama (64)
Alaska (7)
Arizona (249)
Arkansas (14)
Asia (39526)
Australia (6565)
California (7230)
Canada (2255)
China (642)
Colorado (308)
Connecticut (317)
Delaware (179)
Europe (86455)
Florida (1066)
Georgia (236)
Idaho (58)
Illinois (627)
India (26)
Indiana (348)
Iowa (16)
Japan (211)
Kansas (111)
Kentucky (27)
Louisiana (14)
Maine (64)
Maryland (1002)
Massachusetts (5450)
Michigan (240)
Minnesota (437)
Mississippi (3)
Missouri (86)
Montana (30)
Nebraska (25)
Nevada (77)
New Hampshire (69)
New Jersey (2004)
New Mexico (30)
New York (2015)
North Carolina (1110)
North Dakota (9)
Northern California (3160)
Ohio (229)
Oklahoma (15)
Oregon (38)
Pennsylvania (1556)
Puerto Rico (16)
Rhode Island (37)
South America (1112)
South Carolina (32)
South Dakota (1)
Southern California (2686)
Tennessee (118)
Texas (1070)
United States (26891)
Utah (212)
Virginia (176)
Washington D.C. (73)
Washington State (626)
West Virginia (4)
Wisconsin (65)
719,121 Results for "moderna therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vaccines
Moderna Wins FDA Approval for Next-Gen COVID-19 Vaccine Despite ‘Investor Nervousness’
Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the FDA’s attitude toward mRNA and COVID-19 vaccines that have investors worried.
June 2, 2025
·
3 min read
·
Nick Paul Taylor
Vaccines
FDA Asks Pfizer/BioNTech, Moderna To Add Myocarditis Risk to COVID-19 Vaccines
The FDA had given Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge the agency’s directive. The products’ labels already include myocarditis warnings, albeit for different age groups.
May 22, 2025
·
2 min read
·
Tristan Manalac
Infectious disease
Moderna Loses $760M+ Government Bird Flu Contract as Vaccine Uncertainties Mount
The canceled contract comes as Moderna nears a critical FDA decision for its next-generation COVID-19 vaccine.
May 29, 2025
·
2 min read
·
Tristan Manalac
Earnings
Moderna Misses Q1 Revenue Expectations, Plans Another $1.5B in Cuts
Jefferies analysts said Moderna’s first quarter was “in line,” with a miss on revenue offset by a beat on earnings per share.
May 1, 2025
·
3 min read
·
Annalee Armstrong
Vaccines
Moderna Shares Fall as Combo Flu/COVID-19 Vaccine Application Pulled
After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy in eliciting antibodies in data announced earlier this month.
May 21, 2025
·
2 min read
·
Dan Samorodnitsky
Earnings
Moderna Reports Higher-Than-Expected Losses While Anticipating Layoffs
In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal anticipated cuts to the company’s digital team.
February 14, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Moderna to Present at Upcoming Conferences in June 2025
May 27, 2025
·
1 min read
Press Releases
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease
June 13, 2025
·
7 min read
Press Releases
Messenger RNA Market Research Report 2025-2035, Competitive Analysis of Pfizer, GSK, Arcturus Therapeutics, AstraZeneca, Beam Therapeutics, Moderna, Oncotelic, SK Bioscience, Sangamo, Sanofi CureVac
June 11, 2025
·
6 min read
Press Releases
Moderna Announces Update on Investigational Pandemic Influenza Program
May 29, 2025
·
4 min read
1 of 71,913
Next
